Industry News

Gentium receives marketing authorization for Defitelio (R) for the treatment of severe hepatic veno-occlusive disease.

Ganymed Pharmaceuticals receives orphan drug designation from FDA and EMA for IMAB362 for the treatment of pancreatic cancer.

IDT Biologika and Oncotec Pharma Produktion to expand vaccine and oncology capacity.

Beckman Coulter Life Sciences combines its particle characterization business with the Hach Company particle counting business.

Pliva?s new Oral Solid Forms Facility will increase Pliva's production capacities for tablets and capsules.

The Aenova Group will merge with Haupt Pharma, a company specializing in contract development and manufacturing.

Novozymes Biopharma will collaborate with Almac to provide a combined service for drug development applications.

MedPharm opens a new topical and transdermal formulation-development services facility in Guildford, United Kingdom.

The CDMOs DPT Laboratories and Confab will integrate under the leadership of Paul Johnson, group president and COO.

Penn Pharma partners with GEA Pharma to open a new facility for the development and manufacture of oncology drugs.

ISPE has announced the results of its 2013-2014 International Board of Directors election.

PhRMA reports 452 new medicines are in development for rare diseases, including genetic disorders, neurological conditions, infectious diseases, and autoimmune disorders.

The FDA grants Cornerstone Pharmaceuticals orphan drug designation for CPI-613 for the treatment of myelodysplastic syndrome.

Kansas State University to build Bulk Solids Innovation Center in Salina, Kansas.

The US Pharmacopeial Convention posted for public comments on its revisions to the USP Medicare Model Guidelines, which are posted for a 30-day public comment period, beginning Oct. 1, 2013.

GT Biologics has been granted orphan drug designation by FDA Office of Orphan Product Development for Thetanix,

OncoMed Pharmaceuticals has been granted its first US patent on its MAbTrap antibody display technology.

Recipharm has invested EUR 32 million ($43 million) in its Wasserburg, Germany site to expand lyophilization capacity.

Vetter is investing $100 million to expand filling capacity in Germany and the United States.

Sartorius announces offer to acquire TAP Biosystems Group, a UK-based company.

Aesica expands aseptic capabilities at its Nottingham, UK site with the acquisition of new pre-filled syringes manufacturing equipment.

Fujifilm Diosynth Biotechnologies has renewed its manufacturing license from the UK's MHRA.

Catalent has acquired Relthy Laboratorios in Brazil to expand its South American softgel technology business.

ABC Laboratories plans to move operations of its subsidiary, Morse Laboratories, based in California, to Missouri.

Pfenex modifies its contract with US government for Anthrax vaccine.

AMRI has been awarded a seven-year contract for an active ingredient under clinical evaluation.

Carbogen Amcis has made several investments to increase capabilities in supplying antibody drug conjugates.

Hovione's plant in Portugal has successfully passed its twelfth FDA inspection in 18 months.

3M Drug Delivery will manufacture transdermal patch for ProStrakan.

United Drug's Packaging division rebrands as Sharp Packaging.